Skip to main content
Caplight Logo









HaplScience

HaplScience

Private
SeoulHealthcare & Life Scienceshttps://haplnscience.com

Last Round

Series B

Jan 19, 2021

Total Funding Raised

$29.19M

Company Overview

HaplScience is a biotechnology company developing first-in-class therapies for chronic diseases and aging-related conditions based on the HAPLN1 protein.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinedrug discoveryage-related diseaseslongevity biotechtherapeutic developmenttissue repairorganoid technologybiotechnologyanti-aging researchpharmaceutical R&Dlicensing agreementbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HaplScience Comparables

Compare HaplScience with similar companies based on industry and business-model similarity.

HaplScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MediSpan Co., Ltd.
82%
Juvena Therapeutics
81%
Oisín Biotechnologies
80%

HaplScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 19, 2021
Series AJul 12, 2019

HaplScience Investors

Notable investors and investment history

HaplScience investors
InvestorRounds
DSC InvestmentSeries B, Series A
Ministry of Science and ICT of South KoreaGrant
Company K PartnersSeries B, Series A
JB InvestmentSeries B
Lifecore PartnersSeries B
STIC VenturesSeries B
National Research Foundation of KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 1160% MoM, reaching 1.7K.

  • Nov 9, 2025

    Monthly visitors grew 336% MoM, from 434 to 1.9K.

HaplScience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HaplScience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HaplScience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range4
Year FoundedN/A
Last FundingJan 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?